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Summary 
In a number of experimental systems,  the early stage of the apoptotic process, i.e., the stage that 
precedes nuclear disintegration, is characterized by the breakdown of the inner mitochondrial 
transmembrane potential (Aqtm). This A~  m disruption is mediated by the opening of perme- 
ability transition (PT) pores and appears to be critical for the apoptotic cascade,  since it is di- 
rectly regulated by Bcl-2 and since mitochondria induced to undergo PT in vitro become ca- 
pable of  inducing nuclear chromatinolysis in a cell-free system ofapoptosis. Here, we addressed 
the question of which apoptotic events are secondary to mitochondrial PT. We tested the ef- 
fect of a specific inhibitor of PT, bongkrekic acid (BA), a ligand of the mitochondrial adenine 
nucleotide translocator, on a prototypic model of apoptosis: glucocorticoid-induced thymocyte 
death. In addition to abolishing the apoptotic A~,n disruption, BA prevents a number of phe- 
nomena linked to apoptosis: depletion ofnonoxidized glutathione, generation of reactive oxy- 
gen  species,  translocation  of NFKB,  exposure  of phosphatidylserine  residues  on  the  outer 
plasma membrane, cytoplasmic vacuolization, chromatin condensation, and oligonucleosomal 
DNA fragmentation. BA is also an efficient inhibitor of p53-dependent thymocyte apoptosis 
induced by DNA damage. These data suggest that a number of apoptotic phenomena are sec- 
ondary to PT. In addition, we present data indicating that apoptotic Aqr,, disruption is second- 
ary to transcriptional events. These data connect the PT control point to the p53- and ICE/ 
Ced  3-regulated  control points  of apoptosis  and  place  PT  upstream  of nuclear and  plasma 
membrane features of PCD. 
I 
n many models of apoptosis induction, disruption of the 
mitochondrial  transmembrane  potential  (A~m)  is  ob- 
served shortly before other features ofapoptosis (generation 
of reactive  oxygen  species,  plasma  membrane  perturba- 
tions,  chromatin  condensation,  and  DNA  fragmentation) 
become detectable. This applies  to very different cell types 
and protocols ofapoptosis induction (1-5). A~  m disruption 
marks  a  point-of-no-return of the  apoptotic  cascade  (3), 
and mitochondria or mitochondrial products induce chro- 
matin  condensation  and  DNA  fragmentation  in  cell-free 
systems ofapoptosis (5-7). We have recently shown that in 
a cell-free system, mitochondria only become proapoptotic. 
when they undergo permeability transition (PT; 5), a phe- 
nomenon that is also thought to accout for A~,~ disruption 
in intact cells (8). Intriguingly, Bcl-2 is an inhibitor of PT, 
both in isolated mitochondria and in cells (5, 8), underlin- 
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ing that PT may indeed constitute a central checkpoint of 
the apoptotic cascade.  In addition to the putative PT/Bcl-2 
checkpoint,  it  is  currently  assumed  that  the  ICE/Ced3 
family of proteases controls a further apoptotic checkpoint 
(reviewed in 9). Thus far, the hierarchy between these two 
hypothetical control points has remained obscure (10). 
Although published data establish  that end-stage apopto- 
sis is chronologically secondary to PT-mediated A~  m dis- 
ruption (1-4), they do not clarify which features ofapopto- 
sis  are  linked  to  PT  in  a  cause-effect  relationship.  To 
resolve this problem, we have studied the effects of PT in- 
hibition on the apoptotic cascade in a prototypic model of 
apoptosis,  namely the dexamethasone (DEX)-induced death 
of thymocytes (11).  Recently, we have observed that the 
substance that most closely mimics the PT-inhibitory effect 
of Bcl-2,  both  in  cells  and  in  isolated  mitochondria,  is 
bongkrekic acid (BA; 5). BA is a specific ligand of a protein 
located in the inner mitochondrial membrane, the adenine 
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to the structures of the mitochondrial membrane that may 
participate  in the  formation of PT pores,  probably via in- 
teraction with proteins from the outer membrane (13), and 
BA is known to affect the  molecular conformation of the 
ANT, thereby reducing the probability of PT pore gating 
(12,  13).  As  does Bcl-2,  BA inhibits  PT pore  opening in 
response  to  prooxidants,  protonophores,  and  the  ANT 
ligand atractyloside, but fails to interfere with PT induction 
by Ca  2§  and chemical thiol crossqinking (5).  While inhib- 
iting  PT,  both  BA  and  Bcl-2  prevent  the  release  of (a) 
proapoptotic  protein(s)  from mitochondria  (5).  Thus,  BA 
mimics the mitochondrial effects of Bcl-2. 
Here, we tested the effect of BA on cells undergoing apop- 
tosis  rather  than  on isolated  mitochondria.  We  show that 
via its PT-inhibitory (= A~,~,-stabilizing) effect, BA inhibits 
all  major cytoplasmic, plasma membrane,  and nuclear fea- 
tures ofapoptosis. These data establish PT a's a central event 
of the  apoptotic  cascade.  In  addition,  we  addressed  the 
question as to whether proteases from the ICE/Ced3 fam- 
ily  act  upstream  of mitochondria.  Indeed,  inhibition  of 
such proteases prevents the apoptotic ARt dissipation, sug- 
gesting that they act on a level that is hierarchically superior 
to the Bcl-2/PT control point of apoptosis. 
Materials  and Methods 
Culture Conditions and Apoptosis Induction.  Thymocytes were ob- 
tained from female  BALB/c mice (6-10 wk old)  and were cul- 
tured in the absence or presence  ofdexamethasone (DEX; 1 IxM), 
protoporphyrin IX (PPIX; 30  buM), cycloheximide (35  buM), 
actinomycin  D  (3  txM), the  protease  inhibitor  N-tosyl-t-lysyl 
chloromethylketone  ([TLCK]  50  txM; all  reagents  from Sigma 
hnmunochemicals, St.  Louis,  MO), the inhibitor of interleukin- 
1-converting enzyme (ICE)-like proteases N-benzyloxycarbonyl- 
Val-Ala-Asp.fluoromethylketone  (Z-VAD.fmk; Enzyme Systems 
Products, Dublin, CA), R.U-38486 (10 txM; kindly provided by 
l<oussel  Uclaf,  P,  omainville,  France),  and/or  bongkrekic  acid 
(BA), purified  as described  (14) and kindly provided by Dr. Duine 
(Delft University  of Technology, Delft,  The  Netherlands).  The 
standard  dose of BA was 50 IxM during 4-12 h, followed by as- 
sessment of mitochondrial or nuclear parameters  of apoptosis.  Al- 
ternatively,  apoptosis  was induced in thymocytes from C57B1/6 
mice  that  were  rendered  deficient  for p53  by homologous re- 
combination  (kindly  provided  by  F.  l:(advanyi,  Institut  Curie, 
Paris, France).  Thymocytes from p53 -/- animals  (15) or p53 +/+ 
littem~ates were irradiated  (10 Gy) or cultured in the presence of 
etoposide (10 I~M; Sigma) or DEX (10 buM). 
Cytofluorometric Analysis  of Mitochondrial Transmembrane Poten- 
tials, Reactive Oxygen Species, and Nonoxidized Glutathione.  To mea- 
sure A~,,, and superoxide anion generation, cells (5 X 10S/ml) were 
incubated with  3,3'-dihexyloxacarbocyanine iodide  (DiOC~,(3), 
40 nM in PBS; Molecular Probes,  Inc., Eugene, OIL) (3) and di- 
hydroethidine  (HE; 2 I~M) (8)  for 15 min at 37~  followed by 
analysis on  an  Epics  cytofluorometer (Coulter  Corp.,  Hialeah, 
FL) while gating on all cells. Levels of intracellular  thiols  (mainly 
nonoxidized  glutathione)  were  quantitated  using  monochlo- 
robimane (MCB, 40 buM; Molecular Probes)  as a specific probe 
(16). As a negative control, cells were incubated during 30 min with 
the glutathione-depleting  agent N-ethylmaleimide  (50 txM; Sigma). 
Analysis of Nuclear DNA  Loss, Cell  Viability, Phosphatidylserine 
Exposure, and Electron Microscopy.  The  frequency  of subdiploid 
cells was determined by propidium iodine  (PI) staining  of etha- 
nol-permeabilized  cells. The apoptosis-associated increase in mem- 
brane permeability for propidium iodine was assessed as described 
(3). An FITC-annexin V conjugate (1/400 dilution,  I bug/ml, 15 
rain  at  4~  Brand  Applications,  Maastricht,  The  Netherlands) 
with high affinity for PS was used for the assessment of aberrant 
PS exposure (17). Cells were labeled  simultaneously  with ethid- 
ium bromide (EthBr; 200 ng/ml) and FITC-annexin V, and data 
are  shown  for viable  (EthBr-)  cells. DNA  fragmentation  (10  ~' 
cells/lane)  was  determined  by  horizontal  agarose  gel  electro- 
phoresis (3). For electron microscopy, cells were prepared by glu- 
taraldehyde  fixation (2.5% in 0.1 M cacodylate buffer, pH 7.2, 2 h 
at room temperature),  washed twice in cacodylate buffer, fixed in 
2% OsO4,  encapsulated  in agar, dehydrated in  ethanol,  and  em- 
bedded in Epon. Ultrathin sections  were floated  successively on 
uranyl acetate  and lead citrate  solutions  before being observed in 
an AEI6B electron microscope at 60 kV. 
Determination OfNFKB Translocation.  Nuclear  extracts were pre- 
pared according to standard protocols (18). For the gel retardation 
assay, nuclear  proteins  (30  pug) were  preincubated  with  10  lug 
salmon sperm DNA (GIBCO BILL, Cergy, France)  for 15 rain 
on ice before addition of the -~2p-labeled NFKB  oligonucleotide 
probe (5'ACAAGGGACTTTCCGCTGGGGACTTTCCAG 3'; 
2-10  X  t0  s dpm/ng).  Protein-bound oligonucleotide was sepa- 
rated from the free probe using a spin column (GIBCO BRL). 2 
bul of 0.1%  bromophenol blue  and  25  bul  of the  mixture  were 
loaded onto 6% polyacrylamide gel. Electrophoresis was performed 
during 100 rain at 150 V in tris-borate  EDTA buffer, followed by 
autoradiography.  Nuclear  extracts  from  THP1  cells that  were 
stimulated  during 60 min with 20 ng/ml of LPS served as positive 
controls.  As a specifici W control, nuclear extracts were incubated 
in a 1,000-fold excess of unlabeled  NFKB oligonucleotide probe. 
Results and Discussion 
BA,  an  Inhibitor  of Mitochondrial  Permeability  Transition, 
Suppresses  the  DEX-induced  Axlz  Reduction  and  Apoptosis. 
BA is known to affect the  molecular conformation of the 
ANT, thereby reducing the probability of PT pore gating 
(12,  13). We have used this PT inhibitor to address the sig- 
nificance of PT in thymocyte apoptosis. As shown in Fig. 1 
A,  BA  inhibits  the  DEX-induced  A~ m loss.  Concomi- 
tantly,  BA  prevents  the  I)EX-induced  oligonucleosomal 
DNA fragmentation  (Fig.  1 /3) and nuclear DNA loss (Fig. 
1  C-), indicating that inhibition  of PT can prevent the nu- 
clear manifestations  of apoptosis  in  intact  cells.  Transmis- 
sion  electron  microscopy  revealed  that  BA,  when  added 
together  with  DEX,  reduced  significantly  the  number  of 
cells showing chromatin condensation, as compared to cells 
treated  with  DEX  alone  (Fig.  1  E).  The  dose  of BA  re- 
quired to inhibit  chromatinolysis is the same as that which 
is  necessary to prevent  the  DEX-induced  AxIr,1 reduction 
(Fig.  I  D),  underscoring  the  functional  linkage  between 
both  phenomena.  In  conclusion,  BA  inhibits  the  DEX- 
induced  manifestations  of apoptosis,  both  at  the  level  of 
mitochondria and at the level of chromatin structure. 
Effect  of BA  on Metabolic  and Plasma  Membrane Man!~'sta- 
tions qfApoptosis.  In addition  to inhibiting  nuclear  apop- 
1156  Apoptosis and Mitochondrial  Pemleability Transition Figure 1.  BA inhibits the DEX-induced A~  m  disruption and nuclear apoptosis ofthymocytes. Thymocytes 
were cultured in the presence or absence of DEX (1  ~M) and/or BA (standard dose =  50 laM), and the fol- 
lowing parameters were assessed  after 4 h of culture: DiOCr  staining for the simultaneous assessment of 
A~  m and superoxide anion generation  (A), DNA fragmentation  (B), DNA hypoploidy (x +  SEM, n =  3) 
(C), and apoptotic ultrastructure (E). DNA hypoploidy (C) was also measured 12 h after initiation of cultures. 
In addition, the BA dose necessary  to antagonize the DEX-triggered A~  m  loss, and chromatinolysis  was deter- 
mined (D). The dose-response curve quantifies the effects of BA on DEX-induced  A~,,, reduction and hy- 
poploidy (background values subtracted, values for 4 h as in A and C). Results are representative for five inde- 
pendent experiments. Arrows in E indicate vacuolization of the cytoplasma induced by DEX treatment. Bars, 
10 ~M. 
tosis, BA antagonizes the DEX-induced depletion of intra- 
cellular  glutathione  levels  (Fig.  2  A)  (16),  as  well  as  the 
DEX-triggered hypergeneration of superoxide anions (Fig. 
1 A). This latter result is coherent with the AXtrm-stabilizing 
effect  of BA,  since superoxide radicals are  formed  on  the 
uncoupled respiratory chain,  after PT  has occurred  (8).  In 
accord  with  its  effect  on  the  cellular redox  potential, BA 
prevents the DEX-stimulated NFKB translocation (Fig. 2  B). 
BA  also  abolishes  the  membrane  exposure  of phosphati- 
dylserine residues  (Fig.  2  C)  provoked by DEX,  and  thus 
prevents  one  of the  principal membrane  features  of early 
apoptosis (17,  19). BA also prevents the later loss of cell vi- 
ability affecting  DEX-treated  thymocytes  (Fig.  2  D)  and 
abolishes  cytoplasmic features  of apoptosis  such  as  vacu- 
olization (Fig. 1 E). In conclusion, prevention of apoptosis- 
associated PT  by BA does  not  only impede  the  A~ m re- 
duction, but also prevents apoptotic changes at the level of 
the cytoplasm and the plasma membrane. 
BA  Does  Not  Act  by  Quenching  Early  Activation  Signals. 
BA is effective in inhibiting chromatinolysis, even when it 
is added up to 2  h  after DEX addition (Fig. 3  A), i.e., at a 
time point at which the glucocorticoid receptor antagonist 
RU38486  fails to  interfere  with  apoptosis,  indicating that 
BA does not  act by quenching  of early glucocorticoid re- 
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tosis. Cells were cultured as in Fig.  1 and the following parameters were 
assessed: cellular content ofMCB-reactive thiols (A), NFKB translocation 
(B), exposure ofphosphatidylserine residues on the cell surface at 4 h  (C), 
and cell viability at  12 h  (D).  For deternfination of MCB-reactive thiols 
(A),  cells  were  stained with  MCB  and analyzed by cytofluometry.  Per- 
centages refer to the frequency ofMCB  I~  cells. Thymocytes treated with 
the  glutathione-depleting  agent  N-ethyhnaleimide  served  as  negative 
controls. NFKB translocation (/3) was determined by gel retardation assays 
of nuclear extracts incubated with a radiolabeled oligonucleotide binding 
to NFKB. Nuclear extract from LPS-activated THP1  cells served as a pos- 
itive control, and cold inhibition by a  l,{)()()-fold  excess of cold oligonu- 
cleotide  as  a  specificity  control.  Phosphatidylserine  exposure  (C)  was 
determined  by  stainmg of viable  (EthBr)  cells  with  FITC-labeled  re- 
combinant annexin V.  Percentages refer to  the frequency of annexin V 
staining cells among the EthBr- population. Cell viability (/3) was deter- 
nfined  by  staining with  PI.  The  percentages  of PI  I~  PI  i'~t  ..........  li.,,., and 
l)l -high cells are given. 
ceptor-mediated activation signals. Moreover, BA does not 
inhibit apoptosis via inhibition with macromolecular syn- 
thesis.  This is suggested by the fact that BA effectively pre- 
vents  the  Aqt  m  disruption  and  chrornatinolysis  of  thy- 
rnocytes responding to  PPIX  (Fig.  3  B),  a  substance  that 
induces PT directly by acting on a mitochondrial receptor 
(20).  PPIX-induced apoptosis is not affected by inhibitors 
of RNA  or protein  synthesis,  yet is  fully antagonized by 
BA  (Fig.  3  B).  Thus,  a  mode  of apoptosis induction that 
does not require macromolecule synthesis is efficiently an- 
tagonized by BA. 
Dissociation between BA-modulated and p53-mediated Apop- 
totic Control.  To  determine  the  putative  relationship  be- 
tween the p53-rnediated control and the mode of action of 
BA, we studied whether BA would conserve its apoptosis- 
inhibitory effect in thyrnocytes from mice hornozygous for 
deletion mutations  of the  antioncogene p53  (2o53-/-).  As 
shown in Fig. 4 A, thyrnocytes from normal C57B1/6 mice 
irradiated  with  10  Gy  exhibit  chrornatinolysis  associated 
with A~,~ reduction. Control experiments confirmed that 
thyrnocytes from mice homozygous for deletion mutations 
of the antioncogene p53 (p53 -/-) fail to undergo apoptosis 
A,oo  i  B  PPIX  DEX 
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Figure  3.  Mechanisms of BA-mediated  inhibition  of DEX-induced 
thymocyte apoptosis.  (A)  Time dependency of the apoptosis-inhibitory 
BA effect. Thymocytes were  cultured during 30 ￿9  in medium alone. 
Thereafter, DEX  (1  p~M) was added to  cultures (time point 0),  and hy- 
poploidy was determined 6 h  later. At different time points, BA (5(11 p~M) 
or  RU38486  were  added  to  cultures.  Control  cultures  of thymocytes 
maiutained in the presence or absence of BA and/or RU38486 displayed 
hypoploidy values ranging between  10  and  16%.  Cells that  were  kept 
with DEX  only exhibited hypoploidy vaRies  of 53  -+  4%.  (B)  Effect of 
BA on PPlX-induced apoptosis. Thymocytes were  cultured with  PPIX 
(30 ~M) or I)EX  (1  btM) in the presence of actinomycin 1) (3 laM), cy- 
cloheximide (35  IzM), or BA (50 ~M), followed by the detemfination of 
mitochondrial and nuclear parameters  of apoptosis after 4  h  of culture. 
PPIX induced a significant increase in the Axp',,Io,,. cells  (39  --- 4% above 
control values) and hypoploid cells (28  -+ 4%). 
N 
O. 
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Figure  4.  tLelationship between  A~,,, and the p53  or protease check 
points of apoptotic regulation. (A) Effects of BA oll p53-dependent apop- 
tosis.  Thymocytes recovered  from  p53'-  and  control  mice  (p53 +/+) 
were irradiated  (10 Gy) as indicated and cultured during 4  h  in the pres- 
ence ofetoposide (10 ~M), DEX (1  p.M), and/or BA (50 p.M), followed 
by determination of mitochondrial and nuclear signs of PC1).  P,  eults are 
representative for three different experiments.  (B)  Effect of protease in- 
hibitors on mitochondrial and nuclear features of apoptosis. Thymocytes 
from p53 +'+ BALB/c mice were cultured during 4 h after irradiation, ad- 
dition of DEX or etoposide, in the presence of the serine protease inhibi- 
tor TLCK (50  btM)  or Z-VAD.fink (50 ~xM), followed by detemmlation 
of A~,,,, P-OS generation, or hypoploidy. 
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etoposide (21, 22). Such p53 -/-  thymocytes also fail to ex- 
hibit  signs  of irradiation-  or  etoposide-induced  A~ m re- 
duction, suggesting that p53 controls a common event up- 
stream  of both  apoptotic  A~n~  dissipation  and  of nuclear 
apoptosis.  Addition of BA to p53 +/+  thymocytes prevents 
both the Axl2"  m reduction and the nuclear signs of apoptosis 
induced by irradiation  or etoposide  (Fig.  4 A). Moreover, 
BA prevents  the  DEX-induced  death both in p53 -/-  and 
in p53 +/+  thymocytes,  indicating  a  complete  dissociation 
between  the  BA-  and  the  p53-regulated  checkpoints  of 
apoptosis. 
Relationship  between  Apoptotic  A vI,  r,,, Disruption  and  Prote- 
ases.  Different types of proteases have been implicated in 
the control of apoptosis, at the level of the initial triggering 
event,  as well as at the  level of the late  effector phase  (9). 
To  determine  whether  ICE-like  proteases  might  act  up- 
stream of PT-mediated  Aqrm disruption,  thymocytes were 
exposed  to  apoptosis inducers  such  as  DEX,  etoposide  or 
y-irradiation, in the presence or absence ofprotease inhibi- 
tors.  The  cysteine  protease  inhibitor  Z-VAD.fmk,  which 
acts on ICE-like proteases  (23, 24), prevents both the A~I~  ~ 
reduction  and nuclear apoptosis  that  are  induced by these 
stimuli  (Fig.  4  B).  Similarly,  the  serine  protease  inhibitor 
TLCK inhibits thymocyte apoptosis, as described (25),  and 
also prevents  A~m reduction  (Fig.  4  B).  Since TLCK and 
specific inhibitors of ICE-like proteases and CPP32 do not 
prevent  the  mitochondrial  release  of a proapoptotic factor 
nor its action on isolated nuclei in a cell-free system (5),  it 
appears that such proteases act upstream rather than down- 
stream of the PT/Bcl-2 control point ofapoptosis. 
Concluding Remarks.  In the  present  paper,  we  demon- 
strate  that  the  PT-inhibitory  substance  BA  does  not  only 
prevent the apoptotic A~ m disruption, but that it also abol- 
ishes  a number of nuclear,  cytoplasmic,  and plasma mem- 
brane  changes  that  characterize  apoptosis.  Thus,  much  as 
the  mitochondrial  oncoprotein Bcl-2,  BA has  an antioxi- 
dant effect (in the sense that it prevents glutathione  deple- 
tion,  superoxide  anion  generation,  and  NFKB  transloca- 
tion; 26) and inhibits PS exposure on the plasma membrane 
(19). These data underline the probable involvement of PT 
as  a  critical  coordinating  event  of the  apoptotic  cascade. 
Our  data  also  suggest  that  the  BA-inhibitable  PT  control 
point is completely independent of p53 and that PT occurs 
secondary  to  the  activation  of certain  cysteine  and  serine 
proteases. This does not exclude that some proteases are ac- 
tivated downstream of PT.  In particular,  it appears that the 
mitochondrial  intermembrane  factor(s)  released  upon  PT, 
which cause(s)  apoptosis in isolated nuclei, is/are  endowed 
with  some  protease  activity  or  can  activate  nuclear  pro- 
teases.  This  assumption  is  based  on  the  observation  that 
several unidentified nuclear proteins become degraded after 
incubation  of isolated  nuclei  with  mitochondrial  factor(s) 
(our  unpublished  observation).  However,  it  is  clear  that 
some  critical  proteases  control  a  checkpoint  upstream  of 
PT, since this is also suggested by the very rapid kinetics of 
protease activation in some models ofapoptosis (27). At the 
present  time,  little  is  known  about  the  mechanisms  by 
which biochemical pathways PT is induced in cells  that are 
undergoing apoptosis. Nevertheless, the present study indi- 
cates  that  in  addition  to  protease  cascades,  mitochondrial 
PT may fulfill a major role in coordinating the death path- 
ways that invariably accompany late-stage apoptosis. 
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